Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

To combat long-overlooked fungal pathogens, researchers and regulators must embrace innovative science and policy.

A brain-eating pathogen continues to wreak havoc in the second series of The Last of Us – which is so far-fetched, right?